LY2189265

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for LY2189265, covering 2014-10-07 to 2015-09-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2189265 in Japanese Patients With Type 2 Diabetes [Phase 2]